506 related articles for article (PubMed ID: 26699479)
21. Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling.
Zhang X; Fan Q; Li Y; Yang Z; Yang L; Zong Z; Wang B; Meng X; Li Q; Liu J; Li H
Oncotarget; 2017 May; 8(18):29785-29794. PubMed ID: 28076850
[TBL] [Abstract][Full Text] [Related]
22. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
23. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
24. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
25. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A; Zhang S; Ribback S; Steinmann S; Sini M; Ament CE; Utpatel K; Song X; Wang J; Pilo MG; Berger F; Wang H; Tao J; Li X; Pes GM; Mancarella S; Giannelli G; Dombrowski F; Evert M; Calvisi DF; Chen X; Evert K
J Exp Clin Cancer Res; 2022 Jun; 41(1):192. PubMed ID: 35655220
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
[TBL] [Abstract][Full Text] [Related]
27. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
[TBL] [Abstract][Full Text] [Related]
29. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
30. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
31. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
Grannas K; Arngården L; Lönn P; Mazurkiewicz M; Blokzijl A; Zieba A; Söderberg O
J Mol Biol; 2015 Oct; 427(21):3407-15. PubMed ID: 25937570
[TBL] [Abstract][Full Text] [Related]
33. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
Park YY; Sohn BH; Johnson RL; Kang MH; Kim SB; Shim JJ; Mangala LS; Kim JH; Yoo JE; Rodriguez-Aguayo C; Pradeep S; Hwang JE; Jang HJ; Lee HS; Rupaimoole R; Lopez-Berestein G; Jeong W; Park IS; Park YN; Sood AK; Mills GB; Lee JS
Hepatology; 2016 Jan; 63(1):159-72. PubMed ID: 26389641
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
Kim GJ; Kim H; Park YN
PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.
Sakai K; Jawaid S; Sasaki T; Bou-Gharios G; Sakai T
Am J Pathol; 2014 Oct; 184(10):2611-7. PubMed ID: 25108224
[TBL] [Abstract][Full Text] [Related]
36. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
37. MOB1 regulates thymocyte egress and T-cell survival in mice in a YAP1-independent manner.
Kato W; Nishio M; To Y; Togashi H; Mak TW; Takada H; Ohga S; Maehama T; Suzuki A
Genes Cells; 2019 Jul; 24(7):485-495. PubMed ID: 31125466
[TBL] [Abstract][Full Text] [Related]
38. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
[TBL] [Abstract][Full Text] [Related]
39. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
[TBL] [Abstract][Full Text] [Related]
40. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.
Oh SH; Swiderska-Syn M; Jewell ML; Premont RT; Diehl AM
J Hepatol; 2018 Aug; 69(2):359-367. PubMed ID: 29758331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
